Clinical Trial Update: Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating intraarticular leukocyte-rich and leukocyte-poor platelet-rich plasma for osteoarthritis of the knee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Leukocyte-rich platelet-rich plasma (LR-PRP) and Leukocyte-poor platelet-rich plasma (LP-PRP)

Snippet

Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand | Conditions: Osteo Arthritis Knee | Phase 2, Phase 3 | Status: COMPLETED